122 related articles for article (PubMed ID: 33180919)
1. We need CD38 STAT-JAK.
Barwick BG; Lonial S
Blood; 2020 Nov; 136(20):2246-2248. PubMed ID: 33180919
[No Abstract] [Full Text] [Related]
2. The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications.
Ogiya D; Liu J; Ohguchi H; Kurata K; Samur MK; Tai YT; Adamia S; Ando K; Hideshima T; Anderson KC
Blood; 2020 Nov; 136(20):2334-2345. PubMed ID: 32844992
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration.
Damerau A; Gaber T; Ohrndorf S; Hoff P
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256266
[TBL] [Abstract][Full Text] [Related]
4. Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.
Lam C; Ferguson ID; Mariano MC; Lin YT; Murnane M; Liu H; Smith GA; Wong SW; Taunton J; Liu JO; Mitsiades CS; Hann BC; Aftab BT; Wiita AP
Haematologica; 2018 Jul; 103(7):1218-1228. PubMed ID: 29622655
[TBL] [Abstract][Full Text] [Related]
5. SnapShot: JAK-STAT signaling.
Mertens C; Darnell JE
Cell; 2007 Nov; 131(3):612. PubMed ID: 17981126
[No Abstract] [Full Text] [Related]
6. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
7. Dynamics and non-canonical aspects of JAK/STAT signalling.
Mohr A; Chatain N; Domoszlai T; Rinis N; Sommerauer M; Vogt M; Müller-Newen G
Eur J Cell Biol; 2012; 91(6-7):524-32. PubMed ID: 22018664
[TBL] [Abstract][Full Text] [Related]
8. Tools and methods for studying the Drosophila JAK/STAT pathway.
Chen Q; Giedt M; Tang L; Harrison DA
Methods; 2014 Jun; 68(1):160-72. PubMed ID: 24685392
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications.
Spano JP; Milano G; Rixe C; Fagard R
Eur J Cancer; 2006 Nov; 42(16):2668-70. PubMed ID: 16963263
[No Abstract] [Full Text] [Related]
10. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
Yang X; Tang Z; Zhang P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
[TBL] [Abstract][Full Text] [Related]
11. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C; González-Rincón J; Onaindia A; Almaráz C; García-Díaz N; Pisonero H; Curiel-Olmo S; Gómez S; Cereceda L; Madureira R; Hospital M; Suárez-Massa D; Rodriguez-Peralto JL; Postigo C; Leon-Castillo A; González-Vela C; Martinez N; Ortiz-Romero P; Sánchez-Beato M; Piris MÁ; Vaqué JP
Haematologica; 2015 Nov; 100(11):e450-3. PubMed ID: 26294736
[No Abstract] [Full Text] [Related]
12. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
Durham GA; Williams JJL; Nasim MT; Palmer TM
Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
[TBL] [Abstract][Full Text] [Related]
13. SnapShot: Jak-STAT Signaling II.
Villarino AV; Gadina M; O'Shea JJ; Kanno Y
Cell; 2020 Jun; 181(7):1696-1696.e1. PubMed ID: 32589961
[TBL] [Abstract][Full Text] [Related]
14. JAK/STAT - Emerging Players in Metabolism.
Dodington DW; Desai HR; Woo M
Trends Endocrinol Metab; 2018 Jan; 29(1):55-65. PubMed ID: 29191719
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Janus kinase/signal transducer and activator of transcription pathway in multiple myeloma is not related to point mutations in kinase and pseudokinase domains of JAK1.
Corbi FC; de Oliveira MB; Morelli VM; Han SW; Renauld JC; Knoops L; Colleoni GW
Leuk Lymphoma; 2014 May; 55(5):1176-80. PubMed ID: 23885837
[TBL] [Abstract][Full Text] [Related]
16. Canonical and non-canonical JAK-STAT signaling.
Li WX
Trends Cell Biol; 2008 Nov; 18(11):545-51. PubMed ID: 18848449
[TBL] [Abstract][Full Text] [Related]
17. Jak/Stat pathway in Waldenström's macroglobulinemia.
Hodge LS; Ansell SM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):112-4. PubMed ID: 21454207
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas.
Nicolae A; Xi L; Pham TH; Pham TA; Navarro W; Meeker HG; Pittaluga S; Jaffe ES; Raffeld M
Leukemia; 2016 Nov; 30(11):2245-2247. PubMed ID: 27389054
[No Abstract] [Full Text] [Related]
19. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.
Seif F; Khoshmirsafa M; Aazami H; Mohsenzadegan M; Sedighi G; Bahar M
Cell Commun Signal; 2017 Jun; 15(1):23. PubMed ID: 28637459
[TBL] [Abstract][Full Text] [Related]
20. [Molecular components of JAK/STAT signaling pathway and its connection with transcription machinery].
Shaposhnikov AV; Komar'kov IF; Lebedeva LA; Shidlovskiĭ IuV
Mol Biol (Mosk); 2013; 47(3):388-97. PubMed ID: 23888769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
